Love this part!
"For us, this is more important than the patent application announcement. When this data hits, and as described above, it’s going to bring with it a degree of preclinical validation for the science, and should bridge to a clinical study near term. That’s when the wider markets will start to take notice of the company, and when this one’s going to start running."